- Mfr:
- Bsp Pharmaceuticals S.p.a.
- Form:
- Injection
Active: Enfortumab Vedotin-Ejfv 30 mg/2mL
25 NDC products found in the FDA database
Active: Enfortumab Vedotin-Ejfv 30 mg/2mL
Active: Brentuximab Vedotin 50.5 mg/10.5mL
83703-0564Active: Polatuzumab Vedotin 50 mg/.001L
50242-0430Active: Enfortumab Vedotin-Ejfv 20 mg/2mL
Active: Telisotuzumab Vedotin 20 mg/mL
43624-0028Active: Telisotuzumab Vedotin 100 mg/5mL
43624-0029Active: Enfortumab Vedotin 10 mg/mL
49187-0214Active: Tisotumab Vedotin 1 mg/mg
83703-0578Active: Tisotumab Vedotin 10 mg/mL
49187-0207Active: Brentuximab Vedotin 5 mg/mL
49187-0212Active: Polatuzumab Vedotin 20 mg/mL
49187-0216Active: Tisotumab Vedotin 1 mg/mg
83703-0579Active: Polatuzumab Vedotin 30 mg/1.88mL
Active: Polatuzumab Vedotin 140 mg/7.52mL
Active: Brentuximab Vedotin 50 mg/10.5mL
78848-0003Telisotuzumab Vedotin
Active: Telisotuzumab Vedotin 100 mg/mL
00074-1055Telisotuzumab Vedotin
Active: Telisotuzumab Vedotin 20 mg/mL
00074-1044Active: Enfortumab Vedotin 20 mg/2mL
83703-0570Active: Enfortumab Vedotin 30 mg/3mL
83703-0571Polatuzumab Vedotin
Active: Polatuzumab Vedotin 30 mg/1.88mL
50242-0103Polatuzumab Vedotin
Active: Polatuzumab Vedotin 140 mg/7.52mL
50242-0105Enfortumab Vedotin
Active: Enfortumab Vedotin 20 mg/2mL
51144-0020Tisotumab Vedotin
Active: Tisotumab Vedotin 40 mg/4mL
51144-0003Enfortumab Vedotin
Active: Enfortumab Vedotin 30 mg/3mL
51144-0030Brentuximab Vedotin
Active: Brentuximab Vedotin 50 mg/10.5mL
51144-0050